Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

11.20 +0.04 (+0.36%)
Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 Next >
News headline image
GSK, PFE, SNY Stocks Fall on Zantac Litigation ↗
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions. 
Via InvestorPlace
News headline image
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms ↗
These companies are at the center of lawsuits claiming Zantac causes cancer. 
Via Investor's Business Daily
News headline image
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗
  
Via Benzinga
News headline image
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds" ↗
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p. 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.